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Protein-protein interactions control a wide variety of natural biological processes. α-Helical 
coiled coils frequently mediate such protein-protein interactions. Due to the relative simplicity 
of their sequences and structures and the ease with which properties such as strength and 
specificity of interaction can be controlled, coiled coils can be designed de novo to deliver a 
variety of non-natural protein-protein-interaction domains. Herein, several de novo designed 
coiled coils are tested for their ability to mediate protein-protein interactions in Escherichia coli 
cells. The set includes a parallel homodimer, a parallel homotetramer, an antiparallel 
homotetramer and a newly designed heterotetramer, all of which have been characterized in 
vitro by biophysical and structural methods. Using a transcription repression assay based on 
reconstituting the Lac repressor, we find that the modules behave as designed in the cellular 
environment. Each design imparts a different property to the resulting Lac repressor-coiled 
coil complexes, resulting in the benefit of being able to reconfigure the system in multiple 
ways. Modification of the system also allows the interactions to be controlled: assembly can 
be tuned by controlling the expression of the constituent components; and complexes can be 
disrupted through helix sequestration. The small and straightforward de novo designed 
components that we deliver are highly versatile and have considerable potential as protein-
protein-interaction domains in synthetic biology where proteins must be assembled in highly 
specific ways. The relative simplicity of the designs makes them amenable to future 








bp, base pairs; CC, coiled coil; E. coli, Escherichia coli; PPI, protein-protein interaction; RNAP, 
RNA polymerase; SUMO, small ubiquitin-related modifier.   
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Protein-protein interactions (PPIs) are involved in most biological processes. As such, 
modulation of these interactions allows control over the behavior of cells and whole 
organisms.1 Thus, the introduction of exogenous PPIs into cells has broad applications in 
synthetic biology where they may be used, for example, in the assembly of nanostructures or 
artificial enzyme cascades, or for regulating the sub-cellular localization of proteins and protein 
assemblies of interest.2-5 
Transcription regulation is one process where PPIs play well-understood roles, and where the 
potential for controlling cellular and organismal behavior is high. Here, transcription factors 
allow a biological system to control the time, location and level at which its genes are 
expressed. This careful spatiotemporal regulation facilitates many complex natural processes 
including differentiation, multicellularity, reproduction and environmental sensing. Such events 
can also be exploited by synthetic biologists to introduce new behaviors into organisms 
through the design of synthetic gene regulatory networks.6  
In their simplest forms, transcription factors achieve transcription activation by recruiting and 
stabilizing RNA polymerase (RNAP) at a promoter, or repression by preventing RNAP from 
accessing a promoter. In most cases, transcription factors bind DNA as oligomers, and, in 
many cases, they interact with other proteins to exert their function. Thus, PPIs are usually 
required for both repression and activation.7,8 In principle, therefore, combining PPI domains 
with protein-DNA interaction domains allows the design of artificial transcription factors that 
may be used to modulate cellular and organismal behavior with high specificity. Such systems 
also provide a test bed for probing potential PPIs for use in other synthetic-biology 
applications.  
PPI domains for synthetic biology can be sourced from natural systems. For example, the 
Gal4 dimerization domain-Gal11P interaction has been used to mediate interactions between 
DNA-binding proteins and between bacterial RNAP subunits and DNA-binding proteins,9-11 
and the λ cI oligomerization domain has been used to make highly cooperative transcriptional 
repressors when fused to various DNA-binding domains.12 A split maltose-binding protein, the 
FK506-binding protein, and a dimerizing single-domain antibody have also been proposed as 
inducible PPIs.13-15 However, the reuse of natural proteins can make it difficult to find PPI 
domains that are orthogonal to host PPIs. Also, precision protein engineering to deliver desired 
properties for a given application can be frustrated by the inherent complexity of natural protein 
domains. De novo protein design—that is, designing protein sequences to adopt prescribed 
structures and perform desired functions from scratch—offers an alternative source of PPIs. 
De novo PPIs can be designed to be relatively simple and their properties should be better 
understood and more controllable than those of their natural counterparts. However, it is 
generally challenging to design PPIs given the complex and often diffuse nature of  protein-
protein interfaces.16 Nonetheless, there is one class of PPI for which the interactions can be 
both predicted and designed from first principles; namely, the α-helical coiled coil (CC). 
CCs are widespread protein-folding motifs often found in natural PPIs, including in 
transcriptional regulators.17-19 CC sequences usually consist of repeating seven-residue motifs 
called heptads, which are labelled abcdefg and mainly have hydrophobic (h) residues at the 
a and d positions. These hxxhxxx patterns direct the folding of amphipathic α helices, two or 
more of which wrap around each other to bury their hydrophobic surfaces and form rope-like 
superhelices.20-22 The relative simplicity of CCs has enabled the elucidation of sequence-to-
structure relationships that can be used as rules to guide the de novo design of sequences to 
adopt specific CC structures.20 Designable characteristics include stability,23 oligomeric 
state,24 whether an assembly is homo- or heteromeric,25 and helix orientation,26,27 which are 
all accessible through variation of the heptad sequence repeat.  
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This versatility of CCs makes them useful as plug-and-play PPI domains, particularly in the 
context of transcriptional regulation.28-32 Natural and designed CCs have also previously been 
used to reconstitute split proteins 33-35 and to co-assemble diverse proteins of interest to give 
multivalent antibodies,36 oligomeric photosynthetic reaction centers,37 cytosolic 
nanostructures,2 and protease-controlled regulatory networks.38 In these examples the 
designed CCs retain their original properties when fused to bulky proteins of interest, and they 
appear to function well with little or no optimization for the cellular environment. 
Here, we test systematically a number of de novo designed CCs for their ability to mediate 
PPIs in Escherichia coli (E. coli) cells using transcription repression as the readout. The set 
initially consisted of designs with diverse quaternary structures that had previously been 
characterized extensively in vitro and through to X-ray crystal structures, including parallel and 
antiparallel homotetrameric CCs.24,27,39 Furthermore, in order to control fully the formation of 
designed PPIs in vivo, we set out to design a system in which the assembly of functional 
domains depended on the expression of a second, regulatory component. Such a system 
requires a heteromeric CC with an oligomeric state greater than two, for example a 
heterotetramer. As our initial tool kit did not contain a heterotetrameric CC, we have designed 
a new obligate A2B2 heterotetramer using sequence-to-structure relationships established by 
us and others.20,21 Heterotetrameric CCs have been achieved in the past by mutating naturally 
occurring homotetramers to convert them from one- to two-peptide systems,40-44 and the 
sequences of these CCs are generally very similar to the naturally derived parents. Therefore, 
the design presented here represents a truly de novo heterotetrameric CC in that it has been 
designed entirely from first principles. This heterotetramer allows the design goal of a tunable 
transcriptional repressor in E. coli to be realized, showing that downstream activity can be 
regulated by controlling CC assembly. 
All of the discussed CCs assemble as designed in vitro and in vivo and will be useful in a 
range of synthetic-biology applications, particularly transcriptional regulation. Our results 
expand the set of de novo designed PPIs that have been validated for use in E. coli and 
demonstrate the practicality of using established CC design rules to address unmet challenges 
in protein assembly in living cells.  
5 
 
RESULTS AND DISCUSSION: 
A set of de novo homomeric coiled coils interact in E. coli 
Recently, de novo dimeric CCs have been used to bring together natural and engineered DNA-
binding domains to control transcription in E. coli  (Figure 1a, Table 1).23,24,28,29 For this new 
study, we sought to expand this set to include the parallel and antiparallel homotetramers, CC-
Tet and apCC-Tet (Figures 1b and 1c, Table 1), which have been characterized thoroughly 
biophysically and structurally.24,27,39 Tetramers were selected because they fold more 
cooperatively than dimers, and they increase the complexity of assemblies that are accessible. 
These are desirable features for synthetic biology that provide increased controllability over 
interactions and greater resistance to noise.45 Highly cooperative transcriptional regulators 
have previously been implemented in synthetic gene circuits in both eukaryotes and 
prokaryotes.12,46 
The tetramers were tested for their ability to mediate PPIs in E. coli using a transcription 
repression assay where the CCs assemble oligomers of a monomeric Lac repressor variant, 
LacI*. Wild-type (WT) LacI is a homotetramer, but effectively it is a dimer of dimers: the 
protomers dimerize and the tetramer is formed by the association of C-terminal helices from 
each protein chain into a four-helix bundle. Therefore, to generate monomers, both the 
tetramerization domain and dimer interface must be disrupted. To do this, in LacI*, the C-
terminal tetramerization domain was removed and a Leu251→Ala substitution that weakens 
dimerization was introduced.47,48 As previously performed with CC-Di,29 CC-Tet and apCC-Tet 
were each fused to the C terminus of LacI*; i.e., effectively replacing the Lac repressor’s WT 
tetramerization domain (Figures 1d-1g).18,49 When expressed in E. coli at basal levels from the 
ParaBAD promoter, both new fusion proteins repressed the reporter gene, GFP, which was 
expressed from the lacUV5 promoter (Figure 1h). Thus, like CC-Di, the tetrameric CCs 
restored assembly of the LacI* complex and its DNA-binding activity; and both represent useful 
additions to the set of de novo CCs that have been tested inside cells.2,3,28,29 Moreover, the 
constructs with the de novo CCs gave stronger levels of repression than a version of LacI* 
with its WT tetramerization domain intact, LacI*-WTtet (Figure 1h). 
LacI*-CC-Tet and LacI*-apCC-Tet should assemble two DNA-binding LacI* dimers, which 
opens the possibility of using them to loop DNA by binding two DNA sites simultaneously, 
thereby increasing repression (Figures 1f and 1g).50,51 This is not expected to occur with the 
LacI*-CC-Di constructs (Figure 1e). Indeed, when the repression assay was performed with a 
reporter plasmid containing two O1 lac operators spaced 92 base pairs (bp) apart,29 both LacI*-
CC-Tet and LacI*-apCC-Tet gave stronger repression than with a single operator site, while 
LacI*-CC-Di did not (Figure 1h). LacI*-apCC-Tet gave an enhancement in repression of 6.5 
on addition of the second operator. This is greater than the 2.2-fold enhancement seen with 
LacI*-WTtet and is comparable to the enhancement observed with the WT Lac repressor. 
Therefore, complex assembly by the de novo CC alone is comparable to complex assembly 
where the WT dimerization and tetramerization interfaces are both intact. 
 
Design and characterization of a novel heterotetramer, CC-Tet-A2B2 
The above homomeric CCs provide synthetic biologists with a range of options for the 
assembly of multi-component complexes within cells. However, some important applications 
cannot be met with homomeric systems. Examples include the subcellular localization or the 
colocalization of functionally distinct proteins. Therefore, we sought to create a system in 
which the assembly of a functional complex was controlled by a separate regulatory 
component. In order to achieve this, it was necessary to design and validate a new type of CC 
component: an obligate heterotetrameric CC.  
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We took the parallel homotetramer, CC-Tet,24 as a starting point because the design principles 
for parallel CCs are better developed than for antiparallel assemblies. An obligate A2B2 
heterotetramer, CC-Tet-A2B2, was derived by redesigning CC-Tet to give two oppositely 
charged peptides, CC-Tet-A and CC-Tet-B, with all glutamate or all lysine residues at the core-
flanking e and g positions of the CC heptad repeat, respectively (Figure 2a, Table 1). These 
peptides were synthesized by solid-phase peptide synthesis, purified to homogeneity (Figures 
S1 and S2) and investigated alone and combined in equimolar concentrations.  
Charge repulsion between like peptides was expected to preclude homomer formation but 
allow heteromer formation between the A and B chains. Consistent with this, circular dichroism 
(CD) spectroscopy showed that in isolation both peptides were largely unfolded in aqueous 
solution with mean residue ellipticity at 222 nm (MRE222) values of ≈ -14000 deg.cm2.dmol-
1.res-1 (Figures 2b, S3 and S4, Table S1). Furthermore, when mixed they interacted to form a 
highly α-helical heteromeric species with an MRE222 value of ≈ -33000 deg.cm2.dmol-1.res-1 
Figures 2b, S5). This heteromer was thermally stable and did not display an unfolding 
transition when heated to 95 °C. Conversely, the isolated peptides were essentially entirely 
unfolded over the investigated temperature range (Figure 2c). The peptides and heteromer 
were also investigated using analytical ultracentrifugation to determine their solution-phase 
molecular weights. Both peptides were monomeric in isolation, while the mixture formed a 
tetramer (Figures 2d-2g, Tables S1-S3). Finally, to determine the stoichiometry of this 
heterotetramer, continuous variation experiments were performed. CD spectra were recorded 
at different ratios of CC-Tet-A and CC-Tet-B (Figure S6a), and the fraction helix observed was 
plotted against the ratio in a Job plot (Figure S6b). The highest amount of helix was observed 
for the 1:1 ratio of CC-Tet-A:CC-Tet-B.  
Together, these biophysical data show that the designed peptides form an obligate A2B2 
heterotetramer in vitro as designed, without significant off-target homomeric interactions. As it 
is based on CC-Tet, which has all-parallel helices, we anticipate that CC-Tet-A2B2 is also a 
parallel coiled-coil tetramer. However, we have not been able to obtain crystals for the 
complex, and, therefore, cannot confirm this by X-ray crystallography at present.  
 
The CC-Tet-A2B2 heterotetramer functions in E. coli 
To determine whether CC-Tet-A2B2 was suitable for use inside cells, it was tested in the 
transcription repression assay. This was initially done by fusing each peptide to the C terminus 
of LacI* (Figure 3a). The fusion proteins were expressed from separate plasmids at basal 
levels from ParaBAD and tested with GFP expressed from lacUV5 as the reporter. Neither LacI*-
CC-Tet-A nor LacI*-CC-Tet-B alone caused repression (Figure 3b). However, when co-
expressed the fusion proteins restored repression, showing that the CC-Tet-A2B2 tetramer was 
able to direct the assembly of a heteromeric LacI* complex containing functional DNA-binding 
dimers. With a second O1 lac operator in the reporter plasmid LacI*-CC-Tet-A2B2 showed a 
small enhancement in repression (Figure S7).  
A heterotetrameric CC offers the potential to co-localize multiple different appended protein 
domains. For example, DNA binding domains could be assembled with transcription activation 
domains or DNA modifying domains to target enzyme activity to specific DNA sequences. As 
a proof of principle, we performed transcription repression assays in which CC-Tet-B was 
fused to the C terminus of SUMO (small ubiquitin-related modifier, Smt3) instead of LacI*. 
SUMO was selected as it is often used as a solubility tag for protein expression and was 
intended to stabilize the otherwise disordered peptide in the E. coli cytoplasm. In this instance, 
the heterotetrameric interaction was expected to produce a complex containing a single DNA-
binding LacI* dimer and two discrete SUMO monomers linked via the heterotetrameric CC 
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(Figure 3c). When LacI*-CC-Tet-A and SUMO-CC-Tet-B were co-expressed transcription 
repression was also observed, albeit at a slightly lower level than with the LacI*-CC-Tet-A2B2 
complex (Figure 3d). This demonstrates that the heterotetramer can be used to co-localize 
distinct protein domains inside cells and in the future SUMO could be replaced with more 
functionally interesting proteins. Furthermore, it shows that the CC sequences do not need to 
be fused to very large partner proteins in order to function within cells, laying the foundations 
for a minimized regulatory CC construct.  
 
Dynamic transcriptional control using de novo coiled coils 
All of the CCs described here have the potential to display dynamic assembly behavior through 
control of their expression at the transcriptional level. The heterotetramer is particularly 
amenable to this type of control because each component may be manipulated independently. 
To this end, we designed a heterotetramer-based regulatory system wherein protein domains 
of interest fused to one type of CC peptide would co-assemble only in the presence of a 
second, regulatory peptide, the expression of which could be controlled independently.  
CC-Tet-A2B2 was used to make a tunable repression system where the level of transcription 
repression by constitutively expressed DNA-binding proteins could be altered by modulating 
the expression of a regulatory component with no DNA-binding activity (Figure 4a). To test 
this, the transcription repression assay described above was modified to allow independent 
control of the expression of the two components of the heterotetrameric CC. Specifically, CC-
Tet-A was fused to the C terminus of a second Lac repressor variant, LacI**, where the 
dimerization interface was weakened even further with an additional Tyr282→Ala 
substitution.49 The resulting protein, LacI**-CC-Tet-A, was expressed from an insulated low-
level constitutive promoter, pro1.52 The additional Tyr282→Ala substitution was necessary 
because LacI* shows dimerization when expressed from this promoter (Figure S8). The 
regulatory component, CC-Tet-B fused to the C terminus of SUMO, was expressed from the 
arabinose-inducible ParaBAD promoter. When this system was tested in E. coli, increasing the 
arabinose concentration, thereby increasing SUMO-CC-Tet-B expression, caused 
incremental increases in transcription repression (Figures 4b and 4c). The strength of 
repression did not increase when the inducer concentration was increased above 0.02% 
arabinose. This was likely because the availability of LacI**-CC-Tet-A monomers became 
limiting once SUMO-CC-Tet-B reached a certain cellular concentration. As above, the SUMO 
domain was used here to improve the in-cell properties of CC-Tet-B. However, this tunable 
repression was also achieved when the peptide was expressed without the SUMO fusion 
partner, showing that isolated CC peptides can also be used effectively in cells (Figure S9). 
Altogether, this demonstrates that the use of heterotetramers allows control over complex 
assembly as designed. 
As a further demonstration of the control achievable with these straightforward components, 
a system where transcription repression could be relieved was designed using the homodimer 
CC-Di (Figure 4d). This homodimeric CC was fused to the C terminus of LacI** and expressed 
from pro1. A second copy of CC-Di was fused to the C terminus of SUMO and this protein, 
SUMO-CC-Di, was expressed from ParaBAD. In the absence of SUMO-CC-Di, LacI**-CC-Di was 
expected to homodimerize and cause transcription repression. On induction with arabinose, 
SUMO-CC-Di was expected to disrupt these homodimers by sequestering the LacI**-CC-Di 
monomers in LacI**-CC-Di/SUMO-CC-Di heterodimers, thereby relieving transcription 
repression. When this system was tested in E. coli, strong repression was observed in the 
absence of arabinose due to LacI**-CC-Di homodimerizing (Figure 4e). In the presence of 
0.2% arabinose, however, transcription repression was greatly reduced, indicating that most 
of the LacI**-CC-Di monomers were sequestered in complexes with the excess SUMO-CC-Di 
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monomers and were therefore not available to form DNA-binding complexes. Therefore, this 




The design and characterization of coiled-coil (CC) protein-protein-interaction (PPI) domains 
for use in vitro is a well-established practice.20,21 We and others are now taking steps to utilize 
such CCs in cells.2,28,29,36-38  Here, we present a set of de novo designed CCs that function 
faithfully both in vitro and in E. coli. We anticipate that these de novo CCs will be useful as 
new PPI domains in a wide range of synthetic-biology applications that require fine control 
over the spatial and temporal assembly of protein domains in cells. These may include the 
assembly of proteinaceous nanostructures, the co-localization of enzymes in cascades, and 
the localization of components to specific sub-cellular environments. 
The set covers a broad region of CC structural space and incudes dimeric and tetrameric 
oligomeric states, parallel and antiparallel topologies, and homo- and heteromeric assemblies. 
Specifically, the set contains three homomeric CCs that had been characterized previously in 
vitro, and a newly designed heterotetramer, CC-Tet-A2B2, which has been designed to fill a 
hitherto unmet set of requirements for controlling more-complex assemblies. This 
heterotetramer is achieved by designing an overall acidic and an overall basic peptide, a 
strategy that has previously been used successfully to generate heteromeric coiled coils. 
23,25,40,41,43 When charged residues are sufficiently close to the inter-helical interface, charge 
repulsion ensures that the peptides do not form homomers. However, these peptides are able 
to form heteromeric assemblies, where charge complementation relieves the repulsion. Thus, 
CC-Tet-A2B2 is an obligate heterotetramer and adds considerable utility to the de novo CC 
toolkit. In addition to the regulatory application demonstrated here, it will be useful in 
applications where multiple functionally distinct components must be co-localized and where 
off-target homomeric interactions are undesirable.  
As demonstrated using a transcription repression assay in which the de novo CCs replace the 
oligomerization domain of the Lac repressor, all tested CCs assemble in E. coli. Thus, these 
short and straightforward modules are able to find their interaction partners in a complex 
cellular environment with no obvious adverse effects on cell viability. However, some 
significant challenges remain before the design of CCs for in vivo applications can be regarded 
as routine. The CCs are all highly stable in vitro and fold in the E. coli cytosol, but they are not 
yet necessarily optimized for performance in cells: their sequences are idealized and highly 
repetitive and their structures contain high localized charge. Given the prevalence of CC 
sequences in nature, as well as the charged nature of some of the components, it is possible 
that the de novo peptides may have unwanted cross reactions with endogenous proteins or 
other macromolecules;53,54 though we see no significant inhibition of cell growth when our 
constructs are expressed. Further investigation is required to determine whether the CCs 
interact with the E. coli proteome. Additionally, it will be interesting to determine how 
predictably the designs behave in the more complex environment of a eukaryotic cell.55  
Finally, by controlling the CC components at the transcriptional level, we have demonstrated 
control over complex assembly and function. For some applications it would be useful to 
achieve faster switching by controlling complex assembly and disassembly post-
translationally, for example through small-molecule binding, chemical modification, or, as 
demonstrated recently, with proteolysis.38 As tetrameric CCs have relatively large hydrophobic 
cores, and consequently are generally very stable, they may be particularly tolerant of changes 
intended to introduce more-sophisticated properties into them. Future work will focus on 
expanding this set of constitutive CC domains to include inducible interactions.  
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MATERIALS AND METHODS: 
De novo heterotetramer design 
The peptides CC-Tet-A and CC-Tet-B contained a=Leu/d=Ile cores. Glu or Lys residues were 
placed at all e and g positions in CC-Tet-A and CC-Tet-B, respectively. In both peptides, Ala 
was placed at all b and c positions. f positions were populated with Lys residues in CC-Tet-A 
or Gln in CC-Tet-B to promote solubility and aid purification, and a single Trp residue was 
placed at position f19 to provide a chromophore for concentration determination. Helix-
capping Gly residues were added to N and C termini. 
Solid-phase peptide synthesis and peptide purification 
All reagents were supplied by Cambridge Reagents or Acros Organics unless otherwise 
stated. Peptides were synthesized on a 0.1 mmol scale by solid-phase peptide synthesis on 
Rink amide resin using a Liberty Blue automated microwave peptide synthesizer (CEM) and 
Fmoc-protected amino acids at 0.2 M in dimethylformamide (DMF). Deprotection was 
performed with 20% (v/v) morpholine (Alfa Aesar) in DMF. Coupling was performed using 0.5 
M 6-Chloro-1-hydroxybenzotriazole in DMF as the activator and 1.0 M N,N’-
Diisopropylcarbodiimide in DMF as the activator base. Following synthesis, peptides were N-
terminally acetylated using acetic anhydride and pyridine in 1:1 DMF/dichloromethane (Sigma 
Aldrich). Peptides were simultaneously cleaved from the resin and side chain deprotected 
using trifluoroacetic acid (TFA) with 5% (v/v) H2O and 5% (v/v) triisopropylsaline. Resin was 
removed by filtration and crude peptides were precipitated with diethyl ether (Honeywell 
Research Chemicals) then isolated by centrifugation. Peptides were dissolved in 1:1 ultrapure 
Milli-Q water/acetonitrile then lyophilized. 
Peptides were purified by reversed-phase HPLC using C18 reversed-phase columns (150 x 
10 mm, 100 Å pore size, Phenomenex). Linear gradients of ultrapure Milli-Q water containing 
0.1% (v/v) TFA and acetonitrile containing 0.1% (v/v) TFA were used. Peptide masses were 
confirmed by MALDI-TOF mass spectrometry with an ultrafleXtreme II mass spectrometer in 
positive-ion reflector mode (Bruker, UK) using an α-cyano-4-hydroxycinnamic acid matrix 
(Fluka Analytical). Fraction purity was confirmed by reversed-phase HPLC using analytical 
C18 reversed-phase columns (100 x 4.6 mm, 100 Å pore size, Phenomenex) with linear 
gradients of the above buffers. Selected fractions were pooled and lyophilized prior to 
biophysical characterization. 
Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy was performed using either a JASCO J-810 or a JASCO 
J-815 spectropolarimeter with a Peltier temperature controller (Jasco, UK). All measurements 
were performed in phosphate buffered saline (8.2 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM 
NaCl, 2.7 mM KCl, pH 7.4). Samples were analyzed in quartz cuvettes. Full spectra were 
measured between 190 and 260 nm with a 1 nm step size, 100 nm.min-1 scanning speed, 1 
nm bandwidth and 1 second response time. Spectra were measured at 5 °C. Variable 
temperature experiments were performed by heating and cooling samples 5–95–5 °C at a rate 
of 40 °C.h-1 whilst monitoring CD at 222 nm at 0.5 °C intervals. Data was buffer subtracted 
then CD (mdeg) was converted to mean residue ellipticity (MRE, deg.cm2.dmol-1.res-1) by 
normalizing for peptide concentration, number of amide bonds and cuvette pathlength. 
Fraction helix (%) was calculated using the following equation (where MREcoil = 640-45T; T, 
temperature (°C); n, number of amide bonds in sample including C-terminal amide):56 
Fraction helix (%)  = 100 × 
MRE222 - MREcoil




Sedimentation velocity analytical ultracentrifugation 
Sedimentation velocity analysis was conducted on CC-Tet-A2B2 at 20 °C in a Beckman-
Optima XL-A analytical ultracentrifuge using an An-60 Ti rotor. Solutions were prepared in 
buffer at a total peptide concentration of 140 μM. Samples were prepared in phosphate 
buffered saline at a volume of 305 μL and loaded into an SV cell with a 12 mm graphite-filled 
centerpiece and quartz windows. The reference channel was loaded with 320 μL buffer. 
Following temperature equilibration at 3 krpm, the sample was spun at 50 krpm. A total of 120 
absorbance scans at 280 nm over a radial range of 5.8 to 7.3 cm were measured at 5 min 
intervals. Data were fitted to a continuous c(s) distribution model using Sedfit, at 99% 
confidence level.57 The baseline, meniscus, frictional ratio (f/f0), and systematic time-invariant 
and radial-invariant noise were fitted. The partial specific volume (v�) for each peptide/peptide 
combination was calculated using Sedfit. The buffer density was calculated using 
SEDNTERP. Example data and fits, continuous c(s) distribution and residuals were plotted 
with residuals shown as a rectangular greyscale bitmap displaying residuals for every scan, 
stacked from top to bottom. 
Sedimentation equilibrium analytical ultracentrifugation 
Sedimentation equilibrium experiments were conducted on heteromer CC-Tet-A2B2 using 12 
mm six-channel epon-charcoal equilibrium cells with quartz windows and an An-50 rotor and 
on peptides CC-Tet-A and CC-Tet-B using SV cells with 12 mm graphite-filled centerpieces 
and quartz windows and an An-60 rotor. All experiments were performed at 20 °C in a 
Beckman-Optima XL-I or XL-A analytical ultracentrifuge. Solutions were prepared in 
phosphate buffered saline at a total peptide concentration of 70 μM. CC-Tet-A2B2 was spun 
at 24–39 krpm and the individual peptides were spun at 45–60 krpm. Absorbance scans at 
280 nm were measured at 3 krpm intervals following an initial equilibration period of 8 h and 
a second equilibration period of 1 h. Data sets were initially fitted to a single ideal species 
model using Ultrascan II (http://www.ultrascan.uthscsa.edu/). 99% confidence limits were 
calculated using Monte Carlo analysis of the obtained fits.  
Plasmid construction 
Design of DNA encoding CC peptides. DNA sequences for CC-Di, CC-Tet, apCC-Tet, CC-
Tet-A and CC-Tet-B were manually designed to reduce repetitive sequences and to optimize 
for E. coli codon usage (Table S4). DNA sequences also contained 5′ and 3′ recognition sites 
for restriction enzymes XbaI and Acc65I, respectively. DNA fragments encoding CC peptides 
were synthesized as GeneArt Strings (Thermo Fisher Scientific) or as GeneStrands (Eurofins 
Genomics). 
GFP reporter plasmid (KanR). The reporter plasmid, pVRb-lacUV5, contained superfolder 
green fluorescent protein (sfGFP)58 expressed from the lacUV5 promoter. The pVRb-lacO1-
lacO1 reporter plasmid contains a second O1 lac operator spaced 92 bp from the first. Both 
plasmids have been described previously.29 
pBAD-LacI* (AmpR) and pVRc-LacI* (CmR) plasmids. The plasmids pBAD-LacI*-CC-Di, 
pBAD-LacI*-CC-Tet, pBAD-LacI*-apCC-Tet, pBAD-LacI*-CC-Tet-B and pVRc-LacI*-CC-Tet-
A were prepared by inserting DNA fragments encoding the peptides into pBAD-LacI* and 
pVRc-LacI*. The pBAD-LacI* and pVRc-LacI* plasmids have been described in detail 
previously.29 These plasmids carried a truncated version of the Lac repressor (residues 1–
332) lacking its C-terminal tetramerization domain (residues 333–360) and contained a point 
mutation, L251A, and XbaI and Acc65I restriction sites for the introduction of the peptide-
encoding DNA fragments at the Lac repressor C terminus via a flexible linker (Figure S10). 
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The LacI*-peptide constructs had N-terminal 6His, T7 and Xpress tags and were expressed 
from the ParaBAD arabinose-inducible promoter. 
pBAD-6H (AmpR) plasmids. The plasmid pBAD-6H was prepared using deletion PCR to 
remove the Lac repressor gene and T7 and Xpress tags from the plasmid pBAD-LacI*. The 
plasmid pBAD-6H-CC-Tet-B was prepared in the same way from pBAD-LacI*-CC-Tet-B.  
pBAD-SUMO (AmpR) plasmids. The plasmids pBAD-SUMO and pBAD-SUMO-CC-Tet-B were 
prepared by inserting the gene for yeast SUMO (Smt3, small ubiquitin-related modifier) into 
pBAD-6H and pBAD-6H-CC-Tet-B, respectively. pBAD-SUMO-CC-Di was made by inserting 
the DNA for CC-Di into pBAD-SUMO. In pBAD-SUMO-CC-Di and pBAD-SUMO-CC-Tet-B the 
peptide genes were fused to the C terminus of SUMO via a flexible linker (Figure S10). In all 
plasmids, SUMO was also fused to an N-terminal 6 His tag.  
Y282A Point mutation. Site-directed mutagenesis was used to introduce a point mutation, 
Y282A, into the LacI* gene to produce the LacI** variant in pBAD-LacI**-CC-Di, pVRc-LacI**-
CC-Tet-A and pBAD-LacI**-WTtet. PCR was performed with mutagenesis primers and the 
resulting blunt-end products were re-circularized.  
Pro1 constitutive promoter. The DNA sequence for pro1 52 was flanked with 5′ and 3′ 
recognition sites for restriction enzymes SpeI and NcoI, respectively (Table S4). The promoter 
sequence was synthesized as a GeneArt String (Thermo Fisher Scientific).  
Constitutive promoter plasmids. The ParaBAD promoter and araC gene were removed from, and 
an SpeI restriction site was introduced into plasmids pVRc-LacI**, pVRc-LacI**-CC-Di and 
pVRc-LacI**-CC-Tet-A. DNA for pro1 was inserted into these plasmids to produce pVRc-pro1-
LacI**, pVRc-pro1-LacI**-CC-Di and pVRc-pro1-LacI**-CC-Tet-A.  
Transcription repression assays 
GFP transcription repression assays were performed as previously described.29 TB28 
(MG1655ΔLacIZYA) E. coli 59 were transformed with the reporter plasmid and sample 
plasmids carrying the proteins of interest. Following antibiotic selection on LB agar plates, 
three or four colonies were selected and grown overnight at 37 °C in 5 mL supplemented M9 
media (M9 minimal media: 42.3 mM Na2HPO4; 21.6 mM KH2PO4; 18.7 mM NH4Cl; 8.56 mM 
NaCl. Supplements: 0.2% (w/v) casamino acids; 10 mM CaCl2; 0.25% (v/v) glycerol; 2 mM 
MgSO4; 2 μg.mL-1 thiamine) with antibiotics as required (ampicillin, 100 µg/mL; 
chloramphenicol, 25 µg/mL; kanamycin, 50 µg/mL). 10 mL fresh supplemented M9 media was 
inoculated with overnight culture and induced with varying arabinose concentrations (0.0–
0.2% (w/v)). Cultures were grown at 37 °C until OD600 ≈ 0.4–0.6. OD600 values were recorded 
to three significant figures using a Lambda Bio UV/Vis spectrometer (PerkinElmer). 5 mL of 
each culture was pelleted (10 min, 5000 rpm, 4 °C) then re-suspended in 250 μL PBS. Two 
100 μL aliquots of each sample were loaded into consecutive wells of a black 96 well 
polypropylene microplate. GFP fluorescence was measured using a FlexStation Microplate 
Reader (Molecular Devices) with excitation and emission wavelengths of 470 nm and 510 nm, 
respectively. GFP/OD600 was calculated for each 100 μL sample then the duplicate 
measurements were averaged. Next, the technical replicates were averaged. Mean values 
were plotted on a bar chart with error bars as one SD from the mean. Fold-repression values 
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Figure 1 De novo designed homomeric coiled coils direct protein-protein interactions in 
E. coli. Helical wheels and X-ray crystal structures for the designed CCs (a) CC-Di,24 (b) CC-
Tet 39 and (c) apCC-Tet.27 (d) Schematic of the transcription repression assay using a mutant 
of the Lac repressor, LacI*, showing the general architecture of the LacI*-CC fusion genes. 
Schematic of the transcription repression assay showing cartoons of (e) a LacI*-CC-Di dimer 
bound to a single DNA site, (f) a LacI*-CC-Tet tetramer bound to two DNA sites and (g) a 
LacI*-apCC-Tet tetramer bound to two DNA sites. The reporter gene, GFP, was expressed 
from the lacUV5 promoter with or without an additional O1 lac operator placed 92 bp upstream 
of the lacUV5 O1 operator. (h) Transcription repression assay results for LacI*-CC-Di, LacI*-
CC-Tet and LacI*-apCC-Tet with each protein expressed at basal levels from ParaBAD and with 





Figure 2 A de novo designed heterotetrameric coiled coil, CC-Tet-A2B2. (a) Helical wheel 
for the designed CC, CC-Tet-A2B2. (b) Representative CD spectra at 5 °C and (c) variable 
temperature CD measurements for the peptides CC-Tet-A and CC-Tet-B and the 
heterotetramer CC-Tet-A2B2, monitoring mean residue ellipticity at 222 nm (MRE222) between 
5 and 95 °C. (d) Sedimentation equilibrium and (e) sedimentation velocity analytical 
ultracentrifugation data for the heterotetramer CC-Tet-A2B2 returning molecular weights of 
12772 Da (3.9 x mean monomer mass) and 13190 Da (4.1 x mean monomer mass), 
respectively. Sedimentation equilibrium analytical ultracentrifugation data for (f) CC-Tet-A and 
(g) CC-Tet-B returning molecular weights of 3591 Da (1.1 x monomer mass) and 3153 Da (1.0 
x monomer mass), respectively. All measurements were performed in phosphate buffered 




Figure 3 The de novo designed heterotetrameric coiled coil folds in E. coli. (a) Schematic 
of the transcription repression assay showing the general architecture of the LacI*-CC fusion 
genes and a LacI*-CC-Tet-A2B2 tetramer bound to a single DNA site. (b) Transcription 
repression assay results for LacI*-CC-Tet-A2B2 with both proteins expressed at basal levels 
from ParaBAD and with a single O1 lac operator site in the reporter plasmid. Error bars are one 
SD from the mean, N=4. (c) Schematic of the transcription repression assay showing the 
general architecture of the LacI*-CC-Tet-A and SUMO-CC-Tet-B fusion genes and a LacI*-
CC-Tet-A2/SUMO-CC-Tet-B2 tetramer bound to a single DNA site. (d) Transcription repression 
assay results for LacI*-CC-Tet-A2/SUMO-CC-Tet-B2 with both proteins expressed at basal 
levels from ParaBAD and with a single O1 lac operator site in the reporter plasmid. Error bars are 




Figure 4 Control of protein-protein interactions in E. coli. (a) Schematic of the 
transcription repression assay using LacI** showing the architecture of the LacI**-CC and 
SUMO-CC fusion genes and a LacI**-CC-Tet-A2/SUMO-CC-Tet-B2 tetramer bound to a single 
DNA site. (b) Transcription repression assay results and (c) fold repression values for LacI**-
CC-Tet-A2/SUMO-CC-Tet-B2 with LacI**-CC-Tet-A expressed from pro1 and SUMO-CC-Tet-
B expressed from ParaBAD with and without induction of SUMO-CC-Tet-B by various arabinose 
concentrations (0.0–0.2%) and with a single O1 lac operator site in the reporter plasmid. Fold 
repression values were calculated relative to the LacI**/SUMO no-coiled coil control. Error 
bars are one SD from the mean, N=4. (d) Schematic of the transcription repression assay 
using LacI** showing the architecture of the LacI**-CC-Di and SUMO-CC-Di fusion genes 
(top), a LacI**-CC-Di homodimer bound to a single DNA site (bottom, left) and LacI**-CC-
Di/SUMO-CC-Di heterodimers displaced from DNA (bottom, right). (e) Transcription 
repression assay results for LacI**-CC-Di expressed from pro1 in the presence of SUMO-CC-
Di expressed from ParaBAD with and without induction of SUMO-CC-Di by 0.2% arabinose and 





Table 1 Sequences of all discussed peptides.  
Peptide Sequence Reference 
Register*        g abcdefg abcdefg abcdefg abcdef  
CC-Di† Ac – G E IAALKQE IAALKKE NAALKWE IAALKQ GYY – NH2 24 
CC-Tet‡ Ac – G E LAAIKQE LAAIKKE LAAIKWE LAAIKQ GAG – NH2 39 
apCC-Tet Ac - G E LEALAQE LEALAKK LKALAWK LKALAQ G - NH2 27 
Register*        cdefg abcdefg abcdefg abcdefg ab  
CC-Tet-A Ac – G AIEKE LAAIEKE LAAIEWE LAAIEKE LA G – NH2 N.A. 
CC-Tet-B Ac – G AIKQK LAAIKQK LAAIKWK LAAIKQK LA G – NH2 N.A. 
 
All peptides are N-terminally acetylated and C-terminally amidated. 
* Peptide heptad registers are indicated above sequences. Peptides are in c- or g-register 
(i.e., excluding the capping Gly residues, they begin at a c or g heptad position). 
† YY mass tag was not included in CC-Di sequence used in E. coli.  
‡ AG mass tag was not included in CC-Tet sequence used in E. coli. 
